Effect of the App Bone@BC Version 4.0 Under the Follow-up for Patients With Early Breast Cancer

Launched by RIGSHOSPITALET, DENMARK · Mar 4, 2022

Keywords

ClinConnect Summary

This clinical trial is studying the effectiveness of a special app called Bone@BC version 4.0 for women with early-stage breast cancer. The goal is to see if using this app, along with regular medical care, can help improve patients' quality of life and boost their confidence in managing their health. The app is designed for women who are postmenopausal and have recently undergone treatments that may cause side effects like weight gain and bone loss.

To participate in the trial, women aged 50 to 70 who speak Danish and have been diagnosed with early breast cancer are eligible, as long as they have access to a smartphone or other internet-connected devices and are willing to use the app. Participants will receive support through the app, designed to empower them and help them manage their health better during follow-up visits. It’s important to note that this trial is not yet recruiting participants, but it aims to provide valuable insights into how technology can support breast cancer survivors.

Gender

FEMALE

Eligibility criteria

• Inclusion Criteria:
• • Postmenopausal women
• • Age 50-70 years
• • Danish speaking
• • Diagnosed with EBC, stage I-III
• • Eligible to receive (neo-) adjuvant chemotherapy or adjuvant treatments
• • Access to an E-mail address
• • Access to smart mobile electronic devices connected to the internet
• • Willingness to have the app installed on the smart mobile electronic devices
• • Ability to work with the app
• Exclusion Criteria:
• • Prior malignancy
• • Pre-existing type 2 diabetes or other metabolic diseases
• • Withdrawn or not given a consent form